scispace - formally typeset
R

Rakesh K. Jain

Researcher at Harvard University

Publications -  1528
Citations -  198912

Rakesh K. Jain is an academic researcher from Harvard University. The author has contributed to research in topics: Angiogenesis & Cancer. The author has an hindex of 200, co-authored 1467 publications receiving 177727 citations. Previous affiliations of Rakesh K. Jain include Government Medical College, Thiruvananthapuram & University of Oslo.

Papers
More filters
Journal ArticleDOI

Tumor Induction of VEGF Promoter Activity in Stromal Cells

TL;DR: The finding that the VEGF promoter of nontransformed cells is strongly activated by the tumor microenvironment points to a need to analyze and understand stromal cell collaboration in tumor angiogenesis.
Journal Article

Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft.

TL;DR: Microvascular permeability and interstitial penetration of sterically stabilized liposomes in both normal s.c. tissue and human colon adenocarcinoma LS174T xenograft were quantified to provide new insights into the mechanisms of transendothelial pathways ofliposomes and improvements in liposome-mediated drug delivery.
Journal ArticleDOI

Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability

TL;DR: It is suggested that eNOS plays a predominant role in VEGF-induced angiogenesis and vascular permeability in vivo, and selective modulation of eN OS activity is a promising strategy for altering angiogenic and vascular porousness in vivo.
Journal ArticleDOI

Multistage nanoparticle delivery system for deep penetration into tumor tissue

TL;DR: In vivo circulationHalf-life and intratumoral diffusion measurements indicate that the multistage nanoparticles exhibited both the long circulation half-life necessary for the EPR effect and the deep tumor penetration required for delivery into the tumor's dense collagen matrix.
Journal ArticleDOI

Lymphatic metastasis in the absence of functional intratumor lymphatics.

TL;DR: Functional lymphatics associated with mouse tumors expressing normal or elevated levels of vascular endothelial growth factor–C (VEGF-C) are examined to suggest that the functional lymphatics in the tumor margin alone are sufficient for lymphatic metastasis and should be targeted therapeutically.